657 related articles for article (PubMed ID: 31028837)
1. A review of bispecific antibodies and antibody constructs in oncology and clinical challenges.
Suurs FV; Lub-de Hooge MN; de Vries EGE; de Groot DJA
Pharmacol Ther; 2019 Sep; 201():103-119. PubMed ID: 31028837
[TBL] [Abstract][Full Text] [Related]
2. Bispecific antibodies: an innovative arsenal to hunt, grab and destroy cancer cells.
Grandjenette C; Dicato M; Diederich M
Curr Pharm Biotechnol; 2015; 16(8):670-83. PubMed ID: 25941884
[TBL] [Abstract][Full Text] [Related]
3. Bispecific antibodies.
Kontermann RE; Brinkmann U
Drug Discov Today; 2015 Jul; 20(7):838-47. PubMed ID: 25728220
[TBL] [Abstract][Full Text] [Related]
4. Bispecific Antibody (bsAb) Construct Formats and their Application in Cancer Therapy.
Acheampong DO
Protein Pept Lett; 2019; 26(7):479-493. PubMed ID: 30864494
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic progress and application of bispecific antibody in cancer.
Kang J; Sun T; Zhang Y
Front Immunol; 2022; 13():1020003. PubMed ID: 36341333
[TBL] [Abstract][Full Text] [Related]
6. The promise of bispecific antibodies: Clinical applications and challenges.
Lim SM; Pyo KH; Soo RA; Cho BC
Cancer Treat Rev; 2021 Sep; 99():102240. PubMed ID: 34119803
[TBL] [Abstract][Full Text] [Related]
7. Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.
Fournier P; Schirrmacher V
BioDrugs; 2013 Feb; 27(1):35-53. PubMed ID: 23329400
[TBL] [Abstract][Full Text] [Related]
8. Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy.
Zhang T; Lin Y; Gao Q
Cancer Biol Med; 2023 Mar; 20(3):181-95. PubMed ID: 36971124
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin Gamma-Like Therapeutic Bispecific Antibody Formats for Tumor Therapy.
Chen S; Li L; Zhang F; Wang Y; Hu Y; Zhao L
J Immunol Res; 2019; 2019():4516041. PubMed ID: 30886871
[TBL] [Abstract][Full Text] [Related]
10. Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies.
Lejeune M; Köse MC; Duray E; Einsele H; Beguin Y; Caers J
Front Immunol; 2020; 11():762. PubMed ID: 32457743
[TBL] [Abstract][Full Text] [Related]
11. Bispecific antibodies and their applications.
Fan G; Wang Z; Hao M; Li J
J Hematol Oncol; 2015 Dec; 8():130. PubMed ID: 26692321
[TBL] [Abstract][Full Text] [Related]
12. Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials.
Hosseini SS; Khalili S; Baradaran B; Bidar N; Shahbazi MA; Mosafer J; Hashemzaei M; Mokhtarzadeh A; Hamblin MR
Int J Biol Macromol; 2021 Jan; 167():1030-1047. PubMed ID: 33197478
[TBL] [Abstract][Full Text] [Related]
13. Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment.
Guo X; Wu Y; Xue Y; Xie N; Shen G
Front Immunol; 2023; 14():1291836. PubMed ID: 38106416
[TBL] [Abstract][Full Text] [Related]
14. Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells.
Urbanska K; Lynn RC; Stashwick C; Thakur A; Lum LG; Powell DJ
J Transl Med; 2014 Dec; 12():347. PubMed ID: 25496493
[TBL] [Abstract][Full Text] [Related]
15. Bispecific Antibody Armed T Cells to Target Cancer Cells.
Thakur A; Lum LG; Mittal S
Methods Mol Biol; 2018; 1722():117-126. PubMed ID: 29264802
[TBL] [Abstract][Full Text] [Related]
16. Tumor-antigen-binding bispecific antibodies for cancer treatment.
Weidle UH; Kontermann RE; Brinkmann U
Semin Oncol; 2014 Oct; 41(5):653-60. PubMed ID: 25440609
[TBL] [Abstract][Full Text] [Related]
17. Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy.
Huang S; van Duijnhoven SMJ; Sijts AJAM; van Elsas A
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3111-3122. PubMed ID: 32989604
[TBL] [Abstract][Full Text] [Related]
18. Bispecific Antibodies (bsAbs): Promising Immunotherapeutic Agents for Cancer Therapy.
Acheampong DO; Adokoh CK; Ampomah P; Agyirifor DS; Dadzie I; Ackah FA; Asiamah EA
Protein Pept Lett; 2017; 24(5):456-465. PubMed ID: 28117014
[TBL] [Abstract][Full Text] [Related]
19. Bispecific antibodies: design, therapy, perspectives.
Sedykh SE; Prinz VV; Buneva VN; Nevinsky GA
Drug Des Devel Ther; 2018; 12():195-208. PubMed ID: 29403265
[TBL] [Abstract][Full Text] [Related]
20. Bispecific antibody based therapeutics: Strengths and challenges.
Thakur A; Huang M; Lum LG
Blood Rev; 2018 Jul; 32(4):339-347. PubMed ID: 29482895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
